Citation Impact
Citing Papers
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
2011
Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production
2005 StandoutNobel
Applying results of randomised trials to clinical practice: impact of losses before randomisation.
1984
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
The EGF receptor family as targets for cancer therapy
2000
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated Donors
1990
Drug‐Induced Toxic Epidermal Necrolysis Treated with Cyclosporin
1989
Targeting epidermal growth factor receptor in head and neck cancer
2002
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer
2003
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Photodynamic therapy for cancer
2003 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
1989 Standout
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
1989 StandoutNobel
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Cancer genes and the pathways they control
2004 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept
2002
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
The Natural History of Chronic Allograft Nephropathy
2003 Standout
Monoclonal antibodies to target epidermal growth factor receptor–positive tumors
2002
Graft-versus-host disease
2009 Standout
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast
2001 StandoutNobel
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression
1996 StandoutNobel
Renal Vascular and Thrombotic Effects of Cyclosporine
1989
Hematopoietic Stem-Cell Transplantation
2006 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Overview of the clinical efficacy of investigational anticancer drugs
2003
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
1993
COMBINED HISTOCOMPATIBILITY LEUKOCYTE ANTIGENMATCHED DONOR BONE MARROW AND RENAL TRANSPLANTATION FOR MULTIPLE MYELOMA WITH END STAGE RENAL DISEASE: THE INDUCTION OF ALLOGRAFT TOLERANCE THROUGH MIXED LYMPHOHEMATOPOIETIC CHIMERISM
1999
Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia
1997
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
THROMBOTIC MICROANGIOPATHIES ASSOCIATED WITH DRUGS AND BONE MARROW TRANSPLANTATION
1996
Integration of EGFR inhibitors with radiochemotherapy
2006
Cyclosporine
1989 Standout
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
2003 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Engraftment syndrome following hematopoietic stem cell transplantation
2001
Cyclosporin and renal graft histology.
1986
Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft‐versus‐host disease: A randomized double‐blind study in patients undergoing allogeneic marrow transplantation
1987
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation
1986
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
1991
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA
1984
Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia
1985
Magnesium in Man: Implications for Health and Disease
2014 Standout
USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA
1982
EFFECTS OF CYCLOSPORIN A ON SUPPRESSOR AND INDUCER T LYMPHOCYTES IN PRIMARY BILIARY CIRRHOSIS
1980
Acute Myeloid Leukemia
2015 Standout
Primary Biliary Cirrhosis
1987 Standout
THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS
1985
Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy.
1999
ASSOCIATION BETWEEN CYCLOSPORIN NEUROTOXICITY AND HYPOMAGNESAEMIA
1984
Cyclosporin a for the treatment of systemic lupus erythematosus
1981
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
2006 Standout
Evolution of Liver Transplantation
1982
Marrow Transplantation for Thalassemiaa
1985 StandoutNobel
Marrow Transplantation from Related Donors Other Than HLA-Identical Siblings
1985
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation
1994 Standout
CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS
1979 Standout
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
1987 Standout
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Insulin-Dependent Diabetes Mellitus: The Initial Lesion
1981
CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS
1978 Standout
Cyclosporine nephrotoxicity
1986
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients.
1981
CYCLOSPORIN-A DEPOSITS IN RENAL ALLOGRAFTS
1983
PRETREATMENT OF DONOR BONE MARROW WITH MONOCLONAL ANTIBODY OKT3 FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HISTOCOMPATIBLE BONE-MARROW TRANSPLANTATION
1982
Immunology of Autoimmune Thyroid Diseases
1982 Standout
Nephrotoxicity in bone marrow transplant recipients treated with cyclpsporin A
1983
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
1984 Standout
BONE MARROW TRANSPLANTATION FOR INBORN ERRORS
1981
NEPHROTOXICITY OF CYCLOSPORIN A
1981
Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine
1998
Treatment of acute leukemia in adults with chemoradiotherapy and bone marrow transplantation
1985
Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia
1983
Nephrotoxicity of Cyclosporin a after Allogeneic Marrow Transplantation
1981
Site-Specific Conjugation of Boron-Containing Dendrimers to Anti-EGF Receptor Monoclonal Antibody Cetuximab (IMC-C225) and Its Evaluation as a Potential Delivery Agent for Neutron Capture Therapy
2003
DCIS grading schemes and clinical implications
1999
Early and Late Forms of Cyclosporine Nephrotoxicity: Studies in Cardiac Transplant Recipients
1987
Graft‐versus‐Host Disease
1985
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Use of Flow Microfluorometry in Bone Marrow Transplantationa
1984 StandoutNobel
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft- versus-host disease
1985
The price of immunotherapy
1981
THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA
1980
Allogeneic Bone‐Marrow Transplantation
1983
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
Cyclosporine-Associated Chronic Nephropathy
1984 Standout
Works of John Sloane being referenced
Informed consent: ethical, legal, and medical implications for doctors and patients who participate in randomised clinical trials.
1983
Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer
1996
MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIA
1983
CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MAN
1978
Nature of the toxicity of cyclosporin A in the rat
1981
Biopsy Pathology of the Breast
1985
CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
1980
Consistency achieved by 23 european pathologists in categorizing ductal carcinoma in situ of the breast using five classifications*1
1998